Sustainability of mHealth Effects on Cardiometabolic Risk Factors: Five-Year Results of a Randomized Clinical Trial

被引:9
|
作者
Bernabe-Ortiz, Antonio [1 ]
Pauschardt, Julia [1 ]
Diez-Canseco, Francisco [1 ]
Jaime Miranda, J. [1 ,2 ]
机构
[1] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Ave Armendariz 445, Lima 15074, Peru
[2] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru
基金
英国惠康基金;
关键词
mHealth; low- and middle-income countries; blood pressure; body weight; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; SMOKING-CESSATION; CHRONIC DISEASE; GLOBAL BURDEN; INTERVENTIONS; PREVENTION; MANAGEMENT; ADULTS; MODEL;
D O I
10.2196/14595
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The long-term effects of mobile health (mHealth) interventions have not been documented, especially in resource-constrained settings. Objective: This study aimed to assess the effects of a 1-year mHealth intervention on blood pressure levels and body weight in low-resource urban settings in Peru, 4 years after the completion of the original study. Methods: Four years after the original Grupo de Investigacion en Salud Movil en America Latina (GISMAL) study, we attempted to contact the 212 individuals originally enrolled in the study in Peru. The primary outcomes were systolic and diastolic blood pressure levels and hypertension incidence. Secondary outcome measures were body weight, BMI, and self-reported target behaviors. The study personnel collecting the data were masked to the group assignment. Linear mixed models were used to evaluate the effects of the intervention on primary and secondary outcomes in an intention-to-treat analysis. Results: Data from 164 (77.4%) of the 212 originally enrolled participants were available and analyzed (80 in the intervention group and 84 in the control group). The intervention did not result in changes in systolic (-2.54 mm Hg, 95% CI -8.23 to 3.15) or diastolic (3.41 mm Hg, 95% CI -0.75 to 7.57) blood pressure compared with the control group. The intervention reduced the risk of developing hypertension, but the result was not significant (risk ratio (RR) 0.76, 95% CI 0.45-1.28). However, those who received the intervention had lower body weight (-5.42 kg, 95% CI -10.4 to -0.48) and BMI (-2.56 kg/m2, 95% CI -4.46 to -0.66). In addition, compared to the control participants, those who received >= 50% of the scheduled calls during the intervention had greater reductions in body weight (-6.23 kg, 95% CI -11.47 to -0.99) and BMI (-2.81 kg/m2, 95% CI -4.77 to -0.85). Conclusions: An mHealth intervention comprising motivational interview calls and SMS text messaging appears to have effects on health 4 years after intervention completion. Although there were no effects on blood pressure levels, important reductions in body weight and BMI were seen 5 years after randomization. Thus, mHealth appears to be a promising preventive strategy for noncommunicable diseases in resource-constrained settings.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Improved Fixation in Cement less Unicompartmental Knee Replacement Five-Year Results of a Randomized Controlled Trial
    Pandit, H.
    Liddle, A. D.
    Kendrick, B. J. L.
    Jenkins, C.
    Price, A. J.
    Gill, H. S.
    Dodd, C. A. F.
    Murray, D. W.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2013, 95A (15): : 1365 - 1372
  • [42] Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial
    Saeed Asgary
    Mohammad Jafar Eghbal
    Mahta Fazlyab
    Alireza Akbarzadeh Baghban
    Jamileh Ghoddusi
    Clinical Oral Investigations, 2015, 19 : 335 - 341
  • [43] Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial
    Asgary, Saeed
    Eghbal, Mohammad Jafar
    Fazlyab, Mahta
    Baghban, Alireza Akbarzadeh
    Ghoddusi, Jamileh
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (02) : 335 - 341
  • [44] FIVE-YEAR INCIDENCE AND RISK FACTORS FOR IDIOPATHIC EPIRETINAL MEMBRANES
    Bae, Jeong Hun
    Song, Su Jeong
    Lee, Mi Yeon
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (04): : 753 - 760
  • [45] Beneficial effects of the CorCap cardiac support device: Five-year results from the Acorn Trial
    Mann, Douglas L.
    Kubo, Spencer H.
    Sabbah, Hani N.
    Starling, Randall C.
    Jessup, Mariell
    Oh, Jae K.
    Acker, Michael A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (05): : 1036 - 1042
  • [46] Epidural Analgesia in the Latent Phase of Labor and the Risk of Cesarean Delivery A Five-year Randomized Controlled Trial
    Wang, FuZhou
    Shen, XiaoFeng
    Guo, XiRong
    Peng, YuZhu
    Gu, XiaoQi
    ANESTHESIOLOGY, 2009, 111 (04) : 871 - 880
  • [47] Five-year evaluation of a low-shrinkage Silorane resin composite material: A randomized clinical trial
    Schmidt, Malene
    Dige, Irene
    Kirkevang, Lise-Lotte
    Vaeth, Michael
    Horsted-Bindslev, Preben
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (02) : 245 - 251
  • [48] Clinical evaluation of bulk-fill and universal nanocomposites in class II cavities: Five-year results of a randomized clinical split-mouth trial
    Schoilew, Kyrill
    Fazeli, Shila
    Felten, Anna
    Sekundo, Caroline
    Wolff, Diana
    Frese, Cornelia
    JOURNAL OF DENTISTRY, 2023, 128
  • [49] Physical exercise retards progression of carotid artery atherosclerosis:: A five-year controlled randomized clinical trial
    Rauramaa, R
    Väisänen, SB
    Lakka, TA
    Schmidt-Trucksäss, A
    Halonen, P
    Bouchard, C
    CIRCULATION, 2002, 106 (19) : 735 - 735
  • [50] Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer A Randomized Clinical Trial
    Conroy, Thierry
    Castan, Florence
    Lopez, Anthony
    Turpin, Anthony
    Ben Abdelghani, Meher
    Wei, Alice C.
    Mitry, Emmanuel
    Biagi, James J.
    Evesque, Ludovic
    Artru, Pascal
    Lecomte, Thierry
    Assenat, Eric
    Bauguion, Lucile
    Ychou, Marc
    Bouche, Olivier
    Monard, Laure
    Lambert, Aurelien
    Hammel, Pascal
    JAMA ONCOLOGY, 2022, 8 (11) : 1571 - 1578